SpringWorks Therapeutics Investor Relations Material

SpringWorks Therapeutics Inc. is a biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company leverages a precision medicine approach to develop therapies that target critical pathways in these diseases. SpringWorks' portfolio includes investigational therapies designed to modulate the activity of key proteins and signaling pathways involved in disease progression. The company collaborates with other pharmaceutical firms and research institutions to advance its clinical programs and bring innovative treatments to market. The company is headquartered in Stamford, Connecticut, and its shares are listed on the NASDAQ.